Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;76(11):1484–1488. doi: 10.1038/bjc.1997.582

A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.

T Takenaka 1, K Maruyama 1, T Kinoshita 1, M Sasako 1, T Sano 1, H Katai 1, Y Matsuno 1
PMCID: PMC2228181  PMID: 9400946

Abstract

The standard management of primary gastric lymphoma (PGL) (stage II) has not been established despite the use of various treatment modalities. The present prospective trial of combined surgery and chemotherapy for the treatment of PGL (stage II) included 25 consecutive patients treated between July 1978 and December 1993. Twenty-one patients were treated with total gastrectomy and four with partial gastrectomy; this was followed by post-operative chemotherapy with m-VEPA (vincristine, cyclophosphamide, prednisolone and doxorubicin), followed by consolidation chemotherapy with VEMP (vindesine, cyclophosphamide, methotrexate and prednisolone) or VQEP (vindesine, carbazilquinone, cyclophosphamide and prednisolone). Twenty-one of the 25 patients who completed post-operative chemotherapy were free of relapse 26-203 (median 94) months after the gastrectomy. Of the four patients who did not complete the projected chemotherapy, two relapsed and died of lymphoma. Another patient with recurrent lymphoma died in an accident, and the fourth patient was in remission at 54 months after surgery. The post-operative overall and disease-free survival rates at 10 years for the 25 evaluable patients were 81.6% and 92.0% respectively. Major surgical complications and treatment-related death after chemotherapy were not observed. PGL (stage II) appears to be curable when treated with gastrectomy and adjuvant chemotherapy.

Full text

PDF
1484

Images in this article

1485Figure 1
on p.1485

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellesi G., Alterini R., Messori A., Bosi A., Bernardi F., di Lollo S., Ferrini P. R. Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas. Br J Cancer. 1989 Aug;60(2):244–248. doi: 10.1038/bjc.1989.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brooks J. J., Enterline H. T. Primary gastric lymphomas. A clinicopathologic study of 58 cases with long-term follow-up and literature review. Cancer. 1983 Feb 15;51(4):701–711. doi: 10.1002/1097-0142(19830215)51:4<701::aid-cncr2820510425>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  3. Burgers J. M., Taal B. G., van Heerde P., Somers R., den Hartog Jager F. C., Hart A. A. Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach. Radiother Oncol. 1988 Apr;11(4):319–326. doi: 10.1016/0167-8140(88)90203-4. [DOI] [PubMed] [Google Scholar]
  4. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  5. DAWSON I. M., CORNES J. S., MORSON B. C. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961 Jul;49:80–89. doi: 10.1002/bjs.18004921319. [DOI] [PubMed] [Google Scholar]
  6. Dragosics B., Bauer P., Radaszkiewicz T. Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathologic study of 150 cases. Cancer. 1985 Mar 1;55(5):1060–1073. doi: 10.1002/1097-0142(19850301)55:5<1060::aid-cncr2820550523>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  7. Fisher R. I., Gaynor E. R., Dahlberg S., Oken M. M., Grogan T. M., Mize E. M., Glick J. H., Coltman C. A., Jr, Miller T. P. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993 Apr 8;328(14):1002–1006. doi: 10.1056/NEJM199304083281404. [DOI] [PubMed] [Google Scholar]
  8. Freeman C., Berg J. W., Cutler S. J. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972 Jan;29(1):252–260. doi: 10.1002/1097-0142(197201)29:1<252::aid-cncr2820290138>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  9. Gobbi P. G., Dionigi P., Barbieri F., Corbella F., Bertoloni D., Grignani G., Jemos V., Pieresca C., Ascari E. The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature. Cancer. 1990 Jun 1;65(11):2528–2536. doi: 10.1002/1097-0142(19900601)65:11<2528::aid-cncr2820651123>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  10. Hockey M. S., Powell J., Crocker J., Fielding J. W. Primary gastric lymphoma. Br J Surg. 1987 Jun;74(6):483–487. doi: 10.1002/bjs.1800740620. [DOI] [PubMed] [Google Scholar]
  11. Isaacson P. G., Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology. 1987 May;11(5):445–462. doi: 10.1111/j.1365-2559.1987.tb02654.x. [DOI] [PubMed] [Google Scholar]
  12. Isaacson P., Wright D. H. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983 Oct 15;52(8):1410–1416. doi: 10.1002/1097-0142(19831015)52:8<1410::aid-cncr2820520813>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  13. Lim F. E., Hartman A. S., Tan E. G., Cady B., Meissner W. A. Factors in the prognosis of gastric lymphoma. Cancer. 1977 Apr;39(4):1715–1720. doi: 10.1002/1097-0142(197704)39:4<1715::aid-cncr2820390449>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  14. Maor M. H., Maddux B., Osborne B. M., Fuller L. M., Sullivan J. A., Nelson R. S., Martin R. G., Libshitz H. I., Velasquez W. S., Bennett R. W. Stages IE and IIE non-Hodgkin's lymphomas of the stomach. Comparison of treatment modalities. Cancer. 1984 Dec 1;54(11):2330–2337. doi: 10.1002/1097-0142(19841201)54:11<2330::aid-cncr2820541104>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  15. Maor M. H., Velasquez W. S., Fuller L. M., Silvermintz K. B. Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma. J Clin Oncol. 1990 Feb;8(2):266–271. doi: 10.1200/JCO.1990.8.2.266. [DOI] [PubMed] [Google Scholar]
  16. McKelvey E. M., Gottlieb J. A., Wilson H. E., Haut A., Talley R. W., Stephens R., Lane M., Gamble J. F., Jones S. E., Grozea P. N. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer. 1976 Oct;38(4):1484–1493. doi: 10.1002/1097-0142(197610)38:4<1484::aid-cncr2820380407>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  17. Musshoff K. Klinische Stadieneinteilung der Nicht-Hodgkin-Lymphome. Strahlentherapie. 1977 Apr;153(4):218–221. [PubMed] [Google Scholar]
  18. Pasini F., Ambrosetti A., Sabbioni R., Todeschini G., Santo A., Meneghini V., Perona G., Cetto G. L. Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE. Eur J Cancer. 1994;30A(1):33–36. doi: 10.1016/s0959-8049(05)80014-0. [DOI] [PubMed] [Google Scholar]
  19. Paulson S., Sheehan R. G., Stone M. J., Frenkel E. P. Large cell lymphomas of the stomach: improved prognosis with complete resection of all intrinsic gastrointestinal disease. J Clin Oncol. 1983 Apr;1(4):263–269. doi: 10.1200/JCO.1983.1.4.263. [DOI] [PubMed] [Google Scholar]
  20. Rodriguez V., Cabanillas F., Burgess M. A., McKelvey E. M., Valdivieso M., Bodey G. P., Freireich E. J. Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma. Blood. 1977 Mar;49(3):325–333. [PubMed] [Google Scholar]
  21. Rosenfelt F., Rosenberg S. A. Diffuse histiocytic lymphoma presenting with gastrointestinal tract lesions. The Stanford experience. Cancer. 1980 Apr 15;45(8):2188–2193. doi: 10.1002/1097-0142(19800415)45:8<2188::aid-cncr2820450830>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  22. Salles G., Herbrecht R., Tilly H., Berger F., Brousse N., Gisselbrecht C., Coiffier B. Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs. Am J Med. 1991 Jan;90(1):77–84. doi: 10.1016/0002-9343(91)90509-v. [DOI] [PubMed] [Google Scholar]
  23. Shepherd F. A., Evans W. K., Kutas G., Yau J. C., Dang P., Scott J. G., Farquharson H. A., Francombe W. H., Bailey D., Baker M. A. Chemotherapy following surgery for stages IE and IIE non-Hodgkin's lymphoma of the gastrointestinal tract. J Clin Oncol. 1988 Feb;6(2):253–260. doi: 10.1200/JCO.1988.6.2.253. [DOI] [PubMed] [Google Scholar]
  24. Sheridan W. P., Medley G., Brodie G. N. Non-Hodgkin's lymphoma of the stomach: a prospective pilot study of surgery plus chemotherapy in early and advanced disease. J Clin Oncol. 1985 Apr;3(4):495–500. doi: 10.1200/JCO.1985.3.4.495. [DOI] [PubMed] [Google Scholar]
  25. Shiu M. H., Karas M., Nisce L., Lee B. J., Filippa D. A., Lieberman P. H. Management of primary gastric lymphoma. Ann Surg. 1982 Feb;195(2):196–202. doi: 10.1097/00000658-198202000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Skarin A. T., Rosenthal D. S., Moloney W. C., Frei E., 3rd Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP). Blood. 1977 May;49(5):759–770. [PubMed] [Google Scholar]
  27. Taal B. G., Burgers J. M., van Heerde P., Hart A. A., Somers R. The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. Ann Oncol. 1993 Dec;4(10):839–846. doi: 10.1093/oxfordjournals.annonc.a058390. [DOI] [PubMed] [Google Scholar]
  28. Takenaka T., Konda C., Sakano T., Shimoyama M., Kitahara T., Minato K., Kitaoka H., Hirota T., Itabashi M. [On the significance of multiagent combination chemotherapy for primary gastric malignant lymphoma (author's transl)]. Nihon Gan Chiryo Gakkai Shi. 1981 Oct 20;16(6):1310–1316. [PubMed] [Google Scholar]
  29. Takenaka T., Konda C., Sakano T., Shimoyama M., Kitahara T., Minato K., Kitaoka H. [Combination chemotherapy of primary gastric lymphoma with vincristine, endoxan (cyclophosphamide), prednisolone and adriamycine (VEPA)]. Gan To Kagaku Ryoho. 1982 Feb;9(2):323–329. [PubMed] [Google Scholar]
  30. Tondini C., Giardini R., Bozzetti F., Valagussa P., Santoro A., Bertulli R., Balzarotti M., Rocca A., Lombardi F., Ferreri A. J. Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experience. Ann Oncol. 1993 Dec;4(10):831–837. doi: 10.1093/oxfordjournals.annonc.a058388. [DOI] [PubMed] [Google Scholar]
  31. Wotherspoon A. C., Doglioni C., Diss T. C., Pan L., Moschini A., de Boni M., Isaacson P. G. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993 Sep 4;342(8871):575–577. doi: 10.1016/0140-6736(93)91409-f. [DOI] [PubMed] [Google Scholar]
  32. Wotherspoon A. C., Ortiz-Hidalgo C., Falzon M. R., Isaacson P. G. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991 Nov 9;338(8776):1175–1176. doi: 10.1016/0140-6736(91)92035-z. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES